| |
|
|
|
|
|
|
|||
|
Blood, 19 February 2009, Vol. 113, No. 8, pp. 1661-1669. Prepublished online as a Blood First Edition Paper on October 31, 2008; DOI 10.1182/blood-2008-01-135012.
Submitted January 23, 2008
Center for Stem Cell Biology, Life Sciences Institute, University of Michigan, Ann Arbor, MI, United States * Corresponding author; email: imaillar{at}umich.edu.
Men1 is a tumor suppressor gene mutated in endocrine neoplasms. Besides its endocrine role, the Men1 gene product menin interacts with the Mixed Lineage Leukemia (MLL) protein, a histone H3 lysine 4 methyltransferase. Although menin and MLL fusion proteins cooperate to activate Homeobox (Hox) gene expression during transformation, little is known about the normal hematopoietic functions of menin. Here we studied hematopoiesis after Men1 ablation. Menin loss modestly impaired blood neutrophil, lymphocyte and platelet counts. Without hematopoietic stress, multilineage and myelo-erythroid bone marrow progenitor numbers were preserved, while B lymphoid progenitors were decreased. In contrast, competitive transplantation revealed a marked functional defect of long-term hematopoietic stem cells (HSC) in the absence of menin, despite normal initial homing of progenitors to the bone marrow. HoxA9 gene expression was only modestly decreased in menin-deficient HSCs. These observations reveal a novel and essential role for menin in HSC homeostasis that was most apparent during situations of hematopoietic recovery, suggesting that menin regulates molecular pathways that are essential during the adaptive HSC response to stress.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||